Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients

European Journal of Clinical Nutrition

Volumn 66, Issue 11, 2012, Pages 1214-1218

  Yilmaz, R ^a   Akoglu, H ^a   Altun, B ^a   Yildirim, T ^a   Arici, M ^a   Erdem, Y ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

albuminuria; hypertension; inflammation; salt intake

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; SODIUM;

ADULT; ALBUMIN URINE LEVEL; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERTENSION; PROTEIN BLOOD LEVEL; SALT INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; ALBUMINURIA; C-REACTIVE PROTEIN; DIET; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SODIUM; SODIUM CHLORIDE, DIETARY;

EID: 84868636024     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.110     Document Type: Article

References (40)

1. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848-851.
2. Ritz E, Dikow R, Morath C, Schwenger V. Salt - a potential 'uremic toxin'?Blood Purif 2006; 24: 63-66.
3. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997; 157: 2449-2452.
4. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ et al. PREVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004; 256: 324-330.
5. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. HOPE Study Investigators. Albuminuria and risk of cardiovascular events and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
6. Pedrinelli R, Dell' Omo G, Di Bello V, Pontremolli R, Microalbuminuria Mariani M. an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002; 16: 79-89.
7. du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15: 222-229.
8. Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED. Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 292: 814-819.
9. Mattar AL, Machado FG, Fujihara CK, Malheiros DM, Zatz R. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition. Clinics 2007; 62: 749-756.
10. Tian N, Gu JW, Jordan S, Rose RA, Hughson MD, Manning Jr. RD. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007; 292: 1018-1025.
11. Roson MI, Cavallero S, Della Penna S, Cao G, Gorzalczany S, Pandolfo M et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 2006; 70: 1439-1446.
12. Franco M, Martinez F, Rodriguez-Iturbe B, Johnson RJ, Santamaria J, Montoya A et al. Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension. Am J Physiol Renal Physiol 2006; 291: 1281-1287.
13. Sanders PW. Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2006; 15: 54-60.
14. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
15. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006; 26: 987-994.
16. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78: 539-552.
17. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.
18. Lijnen PJ, Petrov VV, Fagard RH. Association between transforming growth factor-beta and hypertension. Am J Hypertens 2003; 16: 604-611.
19. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 2002; 82: S12-S22.
20. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 2006; 25: S247-S255.
21. Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ et al. Individual blood pressure responses to changes in salt intake: results from the DASH-sodium trial. Hypertension 2003; 42: 459-467.
22. Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM et al. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension 1999; 34: 472-477.
23. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27: 481-490.
24. Guyton AC. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens 1989; 2: 575-585.
25. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. Circ Res 1969; 24: S1-S19.
26. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002; 33: 2744-2749.
27. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol 2002; 83: 13-21.
28. Miles EA, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis 2008; 196: 298-305.
29. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
30. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26: 268-275.
31. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98: 2621-2628.
32. Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990; 15: 900-903.
33. Ying WZ, Sanders PW. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol 1998; 274: 635-641.
34. Ying WZ, Aaron K, Sanders PW. Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1. Am J Physiol Renal Physiol 2008; 295: 406-414.
35. Pedrinelli R, Dell'Omo G, Di Bello V, Pellegrini G, Pucci L, Del Prato S et al. Lowgrade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 2004; 24: 2414-2419.
36. Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I. Interrelationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens 2004; 17: 470-476.
37. Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946-951.
38. Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 2006; 19: 462-466.
39. Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO et al. PREVEND Study Group. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004; 43: 791-796.
40. Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E et al. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study. Am J Kidney Dis 2010; 55: 1050-1959.